[ad_1] DUBLIN and NEW YORK, Jan. 7, 2016 / PRNewswire / – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the acquisition of Anterios, Inc., a clinical-stage biopharmaceutical company developing a novel delivery system generation and prescription botulinum toxin products. Under the agreement, Allergan acquired Anterios for …

Read More »